155P The addition of pyrotinib in early or locally advanced HER2-positive breast cancer patients with no response to two cycles of neoadjuvant therapy: A prospective, multicenter study

Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis

Frontiers in Oncology ◽

10.3389/fonc.2018.00156 ◽

2018 ◽

Vol 8 ◽

Cited By ~ 11

Author(s):

Márcio Debiasi ◽

Carisi A. Polanczyk ◽

Patrícia Ziegelmann ◽

Carlos Barrios ◽

Hongyuan Cao ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Meta Analysis ◽

Locally Advanced ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Changes in Ki 67 expression after neoadjuvant therapy in HER2 positive breast cancer patients treated with trastuzumab and pertuzumab are independent predictors of response and prognosis

European Journal of Cancer ◽

10.1016/s0959-8049(18)30522-7 ◽

2018 ◽

Vol 92 ◽

pp. S98

Author(s):

I.T. Rubio ◽

A. Esgueva-Colmenarejo ◽

R. Rodriguez-Revuelto ◽

V. Peg ◽

V. Marco ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Ki 67 ◽

Predictors Of Response ◽

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s151821 ◽

2018 ◽

Vol Volume 11 ◽

pp. 2091-2096 ◽

Cited By ~ 2

Author(s):

Hikmat Abdel-Razeq ◽

Salwa Saadeh ◽

Mahmoud Abu-Nasser ◽

Hazem Abdulelah ◽

Lina Marie ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Early Stage ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-014-3079-3 ◽

2014 ◽

Vol 147 (1) ◽

pp. 61-68 ◽

Cited By ~ 68

Author(s):

Volkmar Müller ◽

Stephan Gade ◽

Bettina Steinbach ◽

Sibylle Loibl ◽

Gunter von Minckwitz ◽

...

Keyword(s):

Breast Cancer ◽

Translational Research ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Serum Levels ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Research Project ◽

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients

Frontiers in Pharmacology ◽

10.3389/fphar.2020.537265 ◽

2020 ◽

Vol 11 ◽

Author(s):

Jia-qi Yuan ◽

Nian-hua Ding ◽

Zhi Xiao

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Therapeutic Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Oncotarget ◽

10.18632/oncotarget.2449 ◽

2014 ◽

Vol 5 (20) ◽

pp. 9619-9625 ◽

Cited By ~ 22

Author(s):

Patrizia Vici ◽

Marcella Mottolese ◽

Laura Pizzuti ◽

Maddalena Barba ◽

Francesca Sperati ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Pathological Complete Response ◽

Complete Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Abstract P5-16-21: The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients

10.1158/1538-7445.sabcs16-p5-16-21 ◽

2017 ◽

Author(s):

TJ Lillemoe ◽

B Susnik ◽

E Grimm ◽

S-HL Kang ◽

KK Swenson ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Treatment Response ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdt364 ◽

2013 ◽

Vol 24 (12) ◽

pp. 2990-2994 ◽

Cited By ~ 55

Author(s):

V. Guarneri ◽

M.V. Dieci ◽

E. Barbieri ◽

F. Piacentini ◽

C. Omarini ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positivity ◽

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

BMC Medicine ◽

10.1186/s12916-018-1163-y ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 33

Author(s):

Ines Stevic ◽

Volkmar Müller ◽

Karsten Weber ◽

Peter A. Fasching ◽

Thomas Karn ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Her2 Positive ◽

The efficacy and safety of pyrotinib in treating HER2‐positive breast cancer patients with brain metastasis: A multicenter study

Cancer Medicine ◽

10.1002/cam4.4481 ◽

2021 ◽

Author(s):

Min Gao ◽

Chao Fu ◽

Shanshan Li ◽

Fang Chen ◽

Yongteng Yang ◽

...

Keyword(s):

Breast Cancer ◽

Brain Metastasis ◽

Cancer Patients ◽

Multicenter Study ◽

Efficacy And Safety ◽

Breast Cancer Patients ◽

Her2 Positive ◽